CorMedix/$CRMD
About CorMedix
Ticker
Industry
Employees
CorMedix Metrics
$675M
-
-$0.80
1.61
-
Price and volume
Market cap
$675M
Beta
1.61
52-week high
$12.86
52-week low
$2.89
Average daily volume
1.1M
Financial strength
Current ratio
3.958
Quick ratio
3.431
Long term debt to equity
0.669
Total debt to equity
0.948
Interest coverage (TTM)
-839.64%
Management effectiveness
Return on assets (TTM)
-37.69%
Return on equity (TTM)
-65.04%
Valuation
Price to revenue (TTM)
52.467
Price to book
10.96
Price to tangible book (TTM)
11.33
Price to free cash flow (TTM)
-11.452
Growth
Revenue change (TTM)
41,184.20%
Earnings per share change (TTM)
-5.78%
3-year revenue growth (CAGR)
300.94%
3-year earnings per share growth (CAGR)
2.93%
What the Analysts think about CorMedix
Analyst Ratings
CorMedix Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CorMedix Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CorMedix News
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
CorMedix Inc. Added to Nasdaq Biotechnology Index
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
FAQs
What’s the current market cap for CorMedix stock?
What is the P/E ratio for CorMedix stock?
Does CorMedix stock pay dividends?
No, CorMedix (CRMD) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next CorMedix dividend payment date?
CorMedix (CRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for CorMedix?
CorMedix (CRMD) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.